Sequential treatment patterns over time for advanced renal cell carcinoma: data from the German research platform CARAT. 3. August 2023 P J Goebell; C Grüllich; L Müller; M Bögemann; U Martens; E von der Heyde; D Reichert; A Nusch; A Schlenska-Lange; N Wetzel; M Koska; M Jänicke; N Marschner; M Staehler; V Grünwald, 2022. Oncol Res Treat 2022;45(suppl 1):796 Download First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Final results of the NEPTUN study Dechow T, Riera-Knorrenschild J, Hackanson B, Janssen J, Schulz H, Oppermann U, Chiabudini M, von Weikersthal LF, Budweiser S, Nacke A, Taeuscher D, Welslau M,… Weiterlesen Interim analysis (n=150) of the multi-national, prospective, non-interventional ELEANOR study observing real-life extended adjuvant treatment with neratinib in patients with HER2+ / HR+ early breast cancer (eBC). D Lüftner; R Bartsch; U Breitenstein; M Balic; C Jackisch; V Müller; G Rinnerthaler; M Schmidt; M Schwitter; K Zaman; D Wrobel; D Guth; J… Weiterlesen